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Abstract
Gastric cancer is the second leading cause of cancer death worldwide. Predisposing factors include achlorhydria,
Helicobacter pylori infection, oxyntic atrophy and TFF2-expressing metaplasia. In parietal cells, apical potassium channels
comprising the KCNQ1 a subunit and the KCNE2 b subunit provide a K
+ efflux current to facilitate gastric acid secretion by
the apical H
+K
+ATPase. Accordingly, genetic deletion of murine Kcnq1 or Kcne2 impairs gastric acid secretion. Other
evidence has suggested a role for KCNE2 in human gastric cancer cell proliferation, independent of its role in gastric
acidification. Here, we demonstrate that 1-year-old Kcne2
2/2 mice in a pathogen-free environment all exhibit a severe
gastric preneoplastic phenotype comprising gastritis cystica profunda, 6-fold increased stomach mass, increased Ki67 and
nuclear Cyclin D1 expression, and TFF2- and cytokeratin 7-expressing metaplasia. Some Kcne2
2/2mice also exhibited pyloric
polypoid adenomas extending into the duodenum, and neoplastic invasion of thin walled vessels in the sub-mucosa.
Finally, analysis of human gastric cancer tissue indicated reduced parietal cell KCNE2 expression. Together with previous
findings, the results suggest KCNE2 disruption as a possible risk factor for gastric neoplasia.
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Introduction
Gastric cancer remains one of the major causes of mortality,
and the second leading cause of cancer death, worldwide. Gastric
carcinogenesis is a process that progresses through multiple stages
including oxyntic atrophy, ulcer formation, foveolar hyperplasia,
hypo- and achlorhydria and mucous cell metaplasia [1]. Despite
advances in treatment of gastric cancer, relatively little is known
about the molecular mechanisms involved in gastric carcinogen-
esis, the development of normal gastric mucosa into preneoplastic
gastric lesions, or the potential role for ion channels in these
processes.
Parietal cells achieve gastric acidification by virtue of an apical
H
+K
+ATPase (HKA) which pumps protons into the stomach
lumen in exchange for K
+ ions. To maintain this activity, K
+ ions
must travel from the parietal cell into the stomach lumen via the
apical membrane, to ensure continued substrate for the HKA [2].
This K
+ ion efflux occurs through one or more types of apical, K
+-
selective channels. Several inward rectifier (Kir) channels are
implicated in this process based on parietal cell expression and
pharmacological evidence [3,4], but thus far there is genetic
evidence for just one channel fulfilling this role: KCNE2-KCNQ1
[5–7]. KCNQ1 is a six-transmembrane domain a subunit from
the S4 superfamily, which forms functional, voltage-gated,
homotetrameric K
+-selective channels in heterologous expression
studies [8,9]. KCNQ1 can also form heteromeric channel
complexes with ancillary subunits from the KCNE gene family,
and all five known KCNE gene products have been shown to
regulate KCNQ1 function in heterologous expression studies [10].
One, KCNE2, converts KCNQ1 to a voltage-independent,
constitutively-active channel whose current is increased by low
pH. KCNE2 and KCNQ1 are both expressed at or near to the
parietal cell apical membrane, and targeted gene deletion of either
subunit results in achlorhydria due to impaired gastric acid
secretion [5–7]. Thus KCNE2-KCNQ1 channels are considered
essential for gastric acid secretion and thought to provide luminal
K
+ ions as a substrate for the gastric HKA.
Kcnq1
2/2 mice and Kcne2
2/2 mice show similar gastric
phenotypes, characterized by achlorhydria, hypergastrinemia
and gastric glandular hyperplasia [5–7]. Parietal cells from either
null show ,10-fold reduced capacity to recover from proton
loading, suggesting a primary defect in gastric acid secretion.
Kcnq1
2/2 mice also develop metaplasia, dysplasia and pre-
malignant adenomatous hyperplasia of the stomach independent
of infection [11]. This suggests that KCNQ1 dysfunction could
lead to gastric neoplasia independent of H. pylori due to severe
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conjunction with H. pylori could predispose to gastric cancer.
The achlorhydria and gastric hyperplasia we previously
observed in Kcne2
2/2 mice was striking given that the pore-
forming subunit of the complex, KCNQ1, was still present, and in
fact it was strongly expressed in double the number of cells per
gastric gland in Kcne2
2/2 mice compared to Kcne2
+/+ mice [7]. In
a recent study, KCNE2 expression was found to be expressed at
relatively low levels in human gastric tumors and in gastric cancer
cell lines; furthermore, forced over-expression of KCNE2
suppressed the growth of human gastric cancer cells in tissue
culture, and in nude mice [12]. These findings raised the
intriguing possibility that KCNE2 might be involved in gastric
carcinogenesis, and potentially independently of either H. pylori
infection or achlorhydria. Here, to further define the potential role
of KCNE2 in regulation of normal gastric cell growth, we
scrutinized the gastric pathology of Kcne2
2/2 mice up to 15
months of age.
Results
Kcne2
2/2 mice exhibit progressive gastric hyperplasia
We previously demonstrated that Kcne2 is required for normal
regulation of gastric mucosal cell growth: 3-month-old Kcne2
2/2
mice have gastric hyperplasia, achlorhydria and abnormal parietal
cell morphology [7]. Here we compared the stomach mass of 3-
week, 3-month- and 12-15-month-old Kcne2
2/2 mice. The mass of
stomachs at 3 weeks of age were similar for Kcne2
+/+ and Kcne2
2/2
mice, whereas by 3 months there was significant gastric hyperplasia
in Kcne2
2/2 mice. This difference had increased by 12–15 months
to the extent that Kcne2
2/2 mice had stomachs 6-fold larger than
those of Kcne2
+/+ mice of the same age (Figure 1 A).
Kcne2
2/2 mice exhibit gastritis cystic profunda
Even at 3 weeks of age, despite similar stomach mass to that of
Kcne2
+/+ mice, gastric mucosa of Kcne2
2/2 mice already showed
vacuolations close to the basolateral side (Figure 1 B; magnified in
D). To investigate the progression of gastric hyperplasia and its
consequences, a total of eleven 12–15 month-old Kcne2
2/2 mice
and five Kcne2
+/+ mice were histologically examined. The gastric
mucosa in all Kcne2
2/2 mice showed glandular hypertrophy and
diffuse hyperplasia with increased numbers of mucous cells and
parietal cells that were occasionally vacuolated (Figure 1 C).
Strikingly, gastritis cystica profunda (GCP) was observed in 11/11
Kcne2
2/2 mice, but 0/5 of the Kcne2
+/+ mice (x
2 p=0.002)
(magnification of cyst in Figure 1 E). Dilated glands contained cell
debris and, in some but not all Kcne2
2/2 mice, neutrophils. There
was also gastric epithelial hyalinosis with occasional intraluminal
crystals, and lymphoplasmacytic aggregates in the mucosa,
submucosa and muscularis. In some 12–15-month-old Kcne2
2/2
mouse stomachs, prominent lamina proprial fibrosis was noted,
especially in the superficial layers. GCP, also previously referred to
as benign gastric pseudotumor, generally presents as a spectrum of
hyperplastic and metaplastic changes following damage to the
gastric mucosa. While GCP demonstrates histological features
associated with malignancy, it is in itself generally considered
functionally benign - although it has been suggested as a possible
risk factor for gastric cancer [13,14].
Increased proliferative markers in gastric mucosa of
Kcne2
2/2 mice
Importantly, expression of established preneoplastic markers
was increased in Kcne2
2/2 mice compared to Kcne2
+/+ mice. Ki67
antigen is a cell cycle related nuclear protein commonly used as a
proliferation marker in proliferating and neoplastic tissues,
including the stomach [15]. Ki67 staining in sections from
Kcne2
+/+ mouse stomachs (3 months) indicated a small band of
Ki67 positive cells within the isthmic regions of gastric glands,
whereas this proliferative compartment was significantly expanded
in age-matched Kcne2
2/2 mice (Figure 2 A–C). Epithelium lining
cystic areas of GCP in 12-month-old Kcne2
2/2 mice also
demonstrated prominent staining of nuclei with Ki67, indicative
of a high proliferation rate (Figure 2 B).
Cytokeratin (CK)-7 is a 54 kDa polypeptide expressed in a wide
variety of epithelial tissues including lung, breast, and fetal human
stomach; however, it is not expressed in normal adult gastroin-
testinal epithelia [16]. Upregulation of CK-7, indicative of
dedifferentiation, was evident in Kcne2
2/2 gastric mucosa at 12
months; in age-matched Kcne2
+/+ mice, gastric mucosal positive
epithelial cells were much rarer (Figure 2 D). CK-7 was also
prominent around cysts (Figure 2 E).
TFF2-expressing metaplasia in gastric mucosa of
Kcne2
2/2 mice
Trefoil-factor family (TFF)2-expressing metaplasia is associated
with progression to gastric cancer in humans, and in Mongolian
gerbils infected with H. pylori [17]. Gastric mucosa of Kcne2
2/2
mice exhibited areas of metaplasia with prominent TFF2
expression, including in epithelial cells lining cysts (Figure 3 A–
C). TFF2-expressing metaplasia is typically associated with oxyntic
atrophy, characterized as a loss of parietal cells [1]. Here, we
analyzed gastric mucosa from 12-month-old mice with TFF2-
expressing metaplasia for expression of the HKA b subunit (HKA
b), a parietal cell marker. Strikingly, there was no evidence of
oxyntic atrophy in terms of number of parietal cells (Figure 4 A).
Further, HKA b was expressed in cells lining cysts (Figure 4 B).
Increased gastric mucosal Cyclin D1 expression and
gastric neoplasia in Kcne2
2/2 mice
Reduced KCNE2 expression was previously suggested to
enhance proliferation in the gastric cancer cell line SGC7901 via
increased expression of Cyclin D1 [12]. Here, western blots
suggested that Kcne2 gene deletion increased total Cyclin D1
expression in the gastric mucosa of 12-month-old mice (Figure 5
A). Cyclin D1 showed weak and predominantly cytoplasmic
expression at the base of Kcne2
+/+ oxyntic glands (Figure 5 B,C, left
panels), as previously described for normal, proliferating cells in
mouse stomach [18]. In contrast, in Kcne2
2/2 mice, Cyclin D1
showed more widespread and nuclear staining in the neck isthmus
region of gastric glands, and glandular pit (Figure 5 B,C, right
panels). In two of eleven 1-year-old Kcne2
2/2 mice analyzed,
pyloric polypoid adenomas were observed, extending into the
duodenum (Figure 5 D). The same two Kcne2
2/2 mice also
exhibited neoplastic growth in the form of thrombi composed of
fibrin and glandular epithelium, in thin-walled vessels (identified
using endothelial marker CD34) within the gastric submucosa
(Figure 5 E–H).
Reduced parietal cell KCNE2 expression in human gastric
cancer tissue
Given that in a previous study reduced KCNE2 expression was
found to enhance gastric cancer cell line proliferation, and
KCNE2 expression was found to be reduced in human gastric
cancer [12], we examined KCNE2 expression in normal human
gastric mucosa, and gastric cancer tissue. Immunofluorescence
studies revealed striking differences with respect to KCNE2 and
KCNQ1 co-localization, between normal and malignant human
Kcne2 and Gastric Neoplasia
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strongly in parietal cells in normal human gastric mucosa (Figure 6
A), as did KCNQ1 and HKA b (Figure 6 B). In contrast, in human
gastric carcinomas, KCNQ1 and KCNE2 expression rarely
overlapped (Figure 6 C, D), even though KCNQ1 retained its
strong co-localization with HKA b (Figure 6 E). Thus, KCNE2
expression in parietal cells was rarely observed in gastric
carcinoma. The lack of KCNE2-KCNQ1 co-localization was
even more profound in human gastric adenocarcinoma (Figure 6
F), which again retained co-localization of KCNQ1 and HKA b
(Figure 6 G).
Discussion
Potassium channels in proliferative disorders
Potassium channels have emerged as a potential target for
anti-cancer therapies [19], including KCNQ1, hERG and
Kv2.1, all of which are a subunit partners of KCNE2. Disrupted
imprinting caused by mutations in the KCNQ1 gene cause
Beckwith-Wiedemann syndrome (BWS), which predisposes to
cancer [20–22], and KCNQ1 knockout predisposes to gastric
metaplasia [11]. The hERG potassium channel a subunit,
which forms complexes with the KCNE2 ancillary subunit in
Figure 1. Progression of gastric hyperplasia and GCP in Kcne2
2/2 mice. A. Mean stomach weights of Kcne2
+/+ and Kcne2
2/2 mice at 3 weeks, 3
monthsand12months.
{significantly different from samegenotype atprevioustime-point, p,0.005;* significantlydifferentfrom Kcne2
+/+ atsametime-
point, p,0.005; one-way ANOVA. B. H&E-stained sections showing normal gastric mucosa from 3-week-old Kcne2
+/+ (left) and Kcne2
2/2 (right) mice.
Arrows, vacuoles. Scale bar, 200 mm. C. Photomicrograph of H&E-stained sections showing (left) normal gastric mucosa from a 12-month-old Kcne2
+/+
mouse, versus (right) gastritis cystica profunda with three herniated glandular profiles in the submucosa in a Kcne2
2/2 littermate. Arrows, vacuoles.
*Cysts. Scale bar, 300 mm. D. Higher magnification of vacuolated region from gastric mucosa of 3-week-old Kcne2
2/2 mouse from panel B. Arrows,
vacuoles. Scale bar, 30 mm. E. Higher magnification of cystic region from gastric mucosa of 1-year-old Kcne2
2/2 mouse from panel C. Scale bar, 60 mm.
doi:10.1371/journal.pone.0011451.g001
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been identified as a tumor survival factor [24–27] as has Kv2.1
[28].
KCNE2 was previously found to be expressed 2-fold lower in
human gastric cancer tissue than in neighboring normal gastric
cells, and forced upregulation of KCNE2 had anti-proliferative
effects on gastric cancer cells in vitro and injected into nude mice
[12]. The postulated mechanism for this anti-proliferative effect is
down-regulation of Cyclin D1, delaying progression through the
cell cycle [12] similar to what was observed with the hERG
blocker cisapride [29]. Elevated expression of Cyclin D1 in
human gastric tumors correlates with a particularly poor
prognosis [30], therefore understanding factors that increase
Cyclin D1 expression may lead to therapeutic avenues for this
and other forms of cancer. Overexpression of Cyclin D1 has been
suggested to contribute to oncogenesis by disturbing the cell
cycle, and has been reported to be an important oncogenic factor
in esophageal carcinoma [31], and associated with nuclear
accumulation of b-catenin in ovarian endometrioid adenocarci-
nomas [32]; nuclear Cyclin D1 overexpression in gallbladder
carcinomas is a critical event [33].
Here, we describe extensive metaplastic changes in the gastric
muscosa due to genetic disruption of Kcne2. This is associated
with increased nuclear Cyclin D1 expression in the gastric
mucosa, reminiscent of results from previous in vitro studies of
KCNE2 [12]. Neither the current report nor the previous study,
however, delineate the mechanism for Cyclin D1 upregulation
in Kcne2
2/2 mucosa – is it a consequence of metaplastic changes
Figure 2. Upregulation of proliferation markers in Kcne2
2/2 gastric mucosa. A. Immunohistochemical staining for proliferation marker Ki67
indicating an expanded mucosal proliferative compartment in 3-month-old Kcne2
2/2 compared to Kcne2
+/+ mice. Scale bar, 200 mm. B. Ki67 staining
in an ectopic cystic epithelium in the submucosa of a 12-month-old Kcne2
2/2 mouse. Scale bar, 50 mm. C. Higher magnification of gastric mucosa
from different 3-month-old Kcne2
+/+ and Kcne2
2/2 mice from those in panel A, illustrating expansion of proliferative compartment as an increased
number of Ki67-positive cells. Scale bar, 200 mm. D. CK-7 staining in longitudinal sections of gastric glands from 12-month-old Kcne2
+/+ and Kcne2
2/2
mice. Scale bar, 70 mm. E. CK-7 staining in a cystic complex from a 12-month-old Kcne2
2/2 mouse stomach. Scale bar, 70 mm.
doi:10.1371/journal.pone.0011451.g002
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direct association between Kcne2 and Cyclin D1? The study by
Yanglin and colleagues argues for the latter at least in part,
because in their study the Cyclin D1 changes occurred in
isolated cells without the influence of achlorhydria [12]. We
consider that changes secondary to achlorhydria are the most
likely dominant factor, but a direct link cannot be excluded.
Interestingly, hERG, another partner of KCNE2, is expressed in
gastric cancer cells but not normal gastric epithelia, and the
hERG channel blocker cisapride was previously found to
suppress gastric cancer cell growth by inhibiting entry into S
phase from G(1) phase in the cell cycle, increasing apoptosis
[29]. Because KCNE2 partially suppresses hERG currents by
reducing unitary conductance and speeding deactivation [23], it
is an intriguing possibility that the observed anti-proliferative
effects of KCNE2 overexpression in vitro [12] are due to hERG
current suppression promoting apoptosis, and conversely that
KCNE2 down-regulation or genetic disruption may favor
gastric cellular proliferation by increasing hERG current
density.
Figure 3. TFF2-expressing metaplasia in Kcne2
2/2 gastric mucosa. A. Left, Negative control for TFF2 staining in areas of GCP from a Kcne2
2/2
mouse, using IgM isotype. Scale bar, 70 mm. Right, TFF2 staining in areas of GCP from a Kcne2
2/2 mouse, using IgG isotype. Scale bar, 50 mm. B. TFF2
staining in cystic region of gastric mucosa from a Kcne2
2/2 mouse. Scale bar, 50 mm. C. Increased magnification views of TFF2 staining in gastric
mucosa from a Kcne2
2/2 mouse. Left, gastric gland cross-section; right, gastric gland longitudinal section. Scale bar, 50 mm.
doi:10.1371/journal.pone.0011451.g003
Figure 4. No evidence of reduced parietal cell number in Kcne2
2/2 gastric mucosa. A. HKA b subunit staining in longitudinal (upper) and
cross (lower) sections from Kcne2
+/+ and Kcne2
2/2 gastric glands. Scale bars, 100 mm. B. HKA b subunit staining in cystic regions from a Kcne2
2/2
mouse. Scale bars, 100 mm.
doi:10.1371/journal.pone.0011451.g004
Kcne2 and Gastric Neoplasia
PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11451Figure 5. Increased gastric Cyclin D1 expression, and neoplasia, in Kcne2
2/2 mice. A. Western blots of lysates from 3 stomachs per
genotype from Kcne2
2/2 and Kcne2
+/+ mice, using anti-Cyclin D1 (upper) and anti-GAPDH (lower) antibodies. B. Cyclin D1 immunoreactivity at the
base of Kcne2
+/+ oxyntic glands (left) versus more widespread, and nuclear, staining in the mucosa of Kcne2
2/2 mice (right). Scale bars: 70 mm. C.
Higher magnifications of Cyclin D1 immunohistochemistry panels in B. Left, Kcne2
+/+; right, Kcne2
2/2. Scale bars: 40 mm. D. Serosal (left) and mucosal
(right) views of 12-month-old Kcne2
+/+ (upper) and Kcne2
2/2 (lower) mouse stomachs. Arrows: left panel, cystic changes in the gastric serosa; right
panel, pyloric polypoid adenomas extending into the duodenum. E. Left, H&E-stained section showing a thrombus composed of fibrin and glandular
epithelium in a thin-walled vessel within the submucosa of a 12-month-old Kcne2
2/2 mouse (scale bar, 300 mm). Right, expanded view of thrombus
from boxed region in left panel (scale bar, 30 mm). F. CD34 staining of endothelial cells in the thin-walled vessel shown in panel E (brown staining, red
Kcne2 and Gastric Neoplasia
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2/2
mice
GCP can present in human beings with intermittent epigastric
pain, bloating, gastric obstruction or upper gastrointestinal
bleeding, and is most commonly seen in patients with a history
of either gastrectomy or gastrostomy [34]. However, a few cases
have been reported with no association to prior gastric surgery
[35,36]. The pathogenesis of human GCP is believed to arise from
an injury of the muscularis mucosae, which may lead to ectopic
entrapping of gastric glands in the submucosa, muscularis mucosae
or serosa, or from chronic inflammation. GCP is commonly
considered a benign clinical entity, although association with
gastric cancer has been reported [14,37,38].
In laboratory animals, GCP secondary to Helicobacter sp.
infection has been described as a predecessor of intramucosal
dysplasia and neoplasia [39], and associated with development of
gastric carcinoma. GCP was frequently found in H. pylori-infected
Mongolian gerbils that also developed gastric adenocarcinoma
and lymphoid hyperplasia [40]. In a previous murine genetic
model of GCP, TGF beta 1
+/2 mice developed glandular
hyperplastic lesions that shared morphologic features with human
GCP, with mixed inflammatory infiltration of the surrounding
mucosa and chronic vasculitis in the tissues adjacent to these
lesions [41]. Here, in Kcne2
2/2 mice, GCP occurs in the absence
of a primary inflammatory lesion, and independent of vascular
obliteration. Instead, we propose that the primary defect is loss of
the KCNE2 b subunit from channel complexes with KCNQ1,
thereby impairing an important apical K
+ recycling pathway in
parietal cells and preventing gastric acidification by the parietal
cell HKA. While this represents a ‘functional atrophy’ in the
parietal cell population, in previous studies of intestinal metaplasia
an actual loss of parietal cells, termed ‘oxyntic atrophy’, was
considered an important process in the etiology of intestinal
metaplasia, associated with acid reflux disease or H. pylori
infection, and is the most common metaplastic process observed
in the upper gastrointestinal tract [42].
Oxynticatrophy in the absence of significantinflammation can
be induced by DMP-777, a neutrophil elastase inhibitor which
also targets parietal cells due to its action as a protonophore [43].
Oxyntic atrophy in gastric-deficient mice, following treatment
with DMP-777, leads rapidly to TFF2-expressing metaplasia,
also referred to as spasmolytic peptide expressing metaplasia
(SPEM) [44]. SPEM is notable because of its strong association
with human gastric adenocarcinoma, and it is observed in the
majority of fundic gland biopsies from human H. pylori-infected
gastritis patients [45]. The appearance of SPEM in Kcne2
2/2
mice in the absence of either H. pylori or classic oxyntic atrophy
suggests that the ‘functional atrophy’ caused by Kcne2 deletion
may be enough to trigger SPEM. One major difference between
Kcne2
2/2 mice and those in the Nozaki study is that Kcne2
2/2
mice are hypergastrinemic, not gastrin-deficient. Another
difference is that DMP-777 disrupts a gastric tubulovesicle
proton gradient without impairing H
+K
+-ATPase function,
whereas targeted Kcne2 disruption prevents H
+/K
+-ATPase
function by removing its luminal substrate, K
+ ions [7,44].
Perhaps this latter mechanism may in the future reveal clues
regarding the critical events in oxyntic atrophy that result in
SPEM: it is currently suggested that SPEM induction results from
a deficiency in parietal cell-secreted regulators of normal gastric
mucosal renewal, which include sonic hedgehog and TGF-a
[46,47] due to loss of parietal cells. Further studies of Kcne2
2/2
parietal cells - which are still present but malfunctioning - may
reveal regulators which they can still secrete, and those which
they cannot.
The gastric mucosa of Kcne2
2/2 mice also show increased
expression of the established proliferation marker Ki67, mani-
festing as an increase in the width of the mucosal proliferative
band, and as Ki67-positive cells lining the cysts in regions of
GCP. Similarly, the de-differentiation marker CK7, not
expressed in 1-year-old Kcne2
+/+ gastric mucosa, was widely
expressed in that of Kcne2
2/2 mice. Taking these and the markers
described above together, the Kcne2
2/2 gastric mucosa exhibits
metaplasia with multiple features of preneoplasia, and in some
cases neoplasia, notably in a specific pathogen-free environment
with no evidence of gastric Helicobacter infection or oxyntic
atrophy, and in the absence of chemical inhibitors of gastric
acidification. Together with the finding here that parietal cell
KCNE2 expression appears to be reduced in human gastric
cancer tissue (Figure 4) and the previous report that KCNE2
inhibits gastric cancer cell proliferation [12], the data suggest
KCNE2 disruption is associated with gastric cancer progression.
Future studies will involve examining whether Kcne2 disruption
increases predisposition to gastric cancer within pathogen and
carcinogen-based protocols, the mechanisms behind these
possible differences, and the potential mechanistic links between
Kcne2, Cyclin D1 and cell cycle perturbation outside the realm of
achlorhydria-associated disease etiology. Furthermore, as
KCNQ1 and KCNE2 are also co-expressed in thyroid epithelial
cells, where they are important for thyroid hormone biosynthesis
[48], it will be of interest to examine a potential role for KCNE2
in abnormal thyrocyte proliferation.
Materials and Methods
Generation and use of gene-targeted mice
All mice described in this study were housed, utilized and
euthanized according to NIH and Cornell University Institutional
Animal Care and Use Committee guidelines. All mice described in
this study were housed, utilized and euthanized according to NIH
and Weill Medical College Institutional Animal Care and Use
Committee guidelines. Ethical approval to breed and harvest tissue
from wild-type and Kcne2
2/2 mice for biomedical research was
approved by Weill Medical College Institutional Animal Care and
Use Committee (protocol 0704-610A). Kcne2
2/2 mice were
generated as previously described from C57BL/6 Kcne2
+/2 x
Kcne2
+/2 crosses [7]. Numerical data were analyzed with EXCEL
software (Microsoft) using one-way analysis of variance (ANOVA)
with statistical significance set at P,0.05.
Histology
For histology and stomach mass quantification, Kcne2
+/+ and
Kcne2
2/2 mice at 3 weeks, 3 months and 12–15 months were
sacrificed using CO2 asphyxiation (5–10 per genotype). Stomachs
were removed post-mortem, stomach mass determined, then
stomach tissue was fixed in 10% neutral buffered formalin,
processed by routine methods and embedded in paraffin wax.
arrows). Gray arrow, glandular epithelium. Scale bar, 50 mm. G. An H&E-stained section from the thin-walled vessel in panel F, illustrating the vessel
wall (red arrow), and invading glandular epithelium (gray arrow) with region of fibrin adhesion (black arrow). Scale bar, 50 mm. H. Internal control for
CD34 staining, showing a blood vessel from the same Kcne2
2/2 mouse stomach as in panels E–G, but without glandular epithelial invasion, stained
with anti-CD34 antibody (brown staining, red arrow). Scale bar, 50 mm.
doi:10.1371/journal.pone.0011451.g005
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PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11451Figure 6. Human parietal cell KCNE2 expression is reduced in gastric carcinomas. A. Immunofluorescence co-labeling of normal (no disease
detected) human gastric glands: KCNQ1 (green) and KCNE2 (red). Arrows: co-localization. Scale bar: 100 mm. B. Immunofluorescence co-labeling of normal
(no disease detected) human gastric glands: KCNQ1 (green) and HKA b (red). Arrows: co-localization. Scale bar: 100 mm. C, D. Immunofluorescence co-
labeling of human gastric glands from an individual with gastric carcinoma: KCNQ1 (green) and KCNE2 (red). Counterstained with DAPI (blue). Scale bar:
100 mm. Arrows: rare co-localization. Panel D shows an example of complete absence of KCNQ1-KCNE2 co-localization. E. Immunofluorescence co-labeling
of human gastric glands from an individual with gastric carcinoma: KCNQ1 (green) and HKA b (red). Counterstained with DAPI (blue). Scale bar: 100 mm.
Yellow indicates co-localization. F. Immunofluorescence co-labeling of a human gastric adenocarcinoma: KCNQ1 (green) and KCNE2 (red). Counterstained
with DAPI (blue). Scale bar: 400 mm. No KCNQ1-KCNE2 co-localization was observed. G. Immunofluorescence co-labeling of a human gastric
adenocarcinoma: KCNQ1 (green) and HKA b (red). Counterstained with DAPI (blue). Scale bar: 100 mm. Yellow indicates co-localization.
doi:10.1371/journal.pone.0011451.g006
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positively-charged Superfrost slides, stained with hematoxylin and
eosin (H&E), and evaluated with an Olympus BX45 microscope.
Immunohistochemistry
Immunohistochemical detection of Ki67, CK-7 and TFF2
(also known as spasmolytic peptide) was performed using a
Discovery XT processor (Ventana Medical Systems). The
primary antibody concentrations used were: 0.05 mg/ml
(rabbit polyclonal anti-Ki67, Vector Labs); 1 mg/ml (mouse
monoclonal anti-CK-7; Abcam); 1 mg/ml (mouse monoclonal
anti-TFF2; Abcam). Preceding primary antibody incubation,
tissue sections were blocked for 30 min in 10% normal goat
serum, 2% BSA in PBS (anti-Ki67); 30 min in 10% normal
goat serum, 2% BSA in PBS and Avidin/Biotin for 8 min (anti-
CK-7); 30 min in 10% normal goat serum, 2% BSA in PBS
and Avidin/Biotin for 4 min (anti-TFF2). Primary antibody
incubation times were: 3 hr (Ki67 and CK-7); 5 hours (anti-
TFF2). Secondary antibody incubations were: 32 min in 1:200
biotinylated goat anti-rabbit IgG (Vector Labs) for Ki67;
60 min in 1:200 biotinylated horse anti-mouse IgG (Vector
Labs) for CK-7 and TFF2. For Ki67 secondary antibody
incubation, Blocker D, Streptavidin-HRP and DAB detection
kit (Ventana Medical Systems) were used according to the
manufacturer’s instructions. For CK-7 and TFF2, mouse IgG1
(5 mg/ml) was used as an isotype negative control, and Blocker
D, Streptavidin-HRP and DAB detection kit (Ventana Medical
Systems) were used.
For Cyclin D1 detection, stomach slides were heated at 58–
60uC for 30 min and then deparaffinized. Endogenous
peroxidase activity was blocked by incubating sections in 1%
hydrogen peroxide in PBS for 15 min (8.3 ml 30% H2O2/
241.7 ml PBS) followed by unmasking of the antigenic epitope
by microwaving in 10 mM Citrate Buffer at high power for
15 min. Slides were cooled for 20 min, washed in distilled
water for 5 min, transferred to PBS and incubated in 10%
normal horse serum (in 2% BSA-PBS diluent) for 30 min in a
humid chamber. Mouse monoclonal anti-cyclin D1-antibody
(Cell Signaling) was added at 1:1000 with 2% BSA in PBS and
incubated overnight at 4uC in a humid chamber. Slides were
rinsed in PBS and the secondary biotinylated horse anti-mouse
IgG antibody (Vector Labs) was applied at 1:500 in PBS for
30 min at RT. Slides were washed and an Avidin-Biotin
Complex (Vectastain ABC Elite Kit, Vector Labs) diluted at
1:25 in PBS was applied for 30 min. The signal was detected
by incubation in 3,3-Diaminobenzidine (Sigma, Batch
No. 026K3767) until the desired color intensity was reached.
After final washes in water, slides were lightly counterstained
in hematoxylin. KCNQ1 and HKA b single labeling and
detection were performed as previously described [7]. CD34
detection was with 1:50 anti-CD34 antibody (AbCam). Slides
were viewed with a Nikon Eclipse E600 microscope and
photographed using a RT Color Camera and SPOT software
(Diagnostic Instruments, Inc.).
Immunofluorescence
All human tissue was obtained from ProSci, Poway, CA, and
was certified as having been obtained from qualified and
licensed pathology services, using appropriate conformed
consent for use in biomedical research and with donor
anonymity protection; therefore, additional Weill Medical
College Institutional Review Board ethics approval was not
required. Immunofluorescence detection of HKA b,K C N Q 1
and KCNE2 in human gastric tissue (ProSci) was performed
using a Discovery XT processor (Ventana Medical Systems).
The following human tissues were used: normal stomach tissue
from a 50-year-old woman (PSC-10-809-XB1); gastric carcino-
ma tissue, patient information unavailable (PSC-10-814-CA1);
gastric adenocarcinoma tissue from a 51-year-old woman (PSC-
10-809-XA1). The primary antibody concentrations used were:
0.5 mg/ml anti- HKA b (mouse monoclonal, Affinity Bior-
eagents), 1 mg/ml anti-KCNQ1 (rabbit or goat polyclonal,
Chemicon), and in-house anti-KCNE2 serum was used at a
1:500 dilution after column-enriching IgG. Preceding the
primary antibody incubation, the tissue sections were blocked
for 30 min in 10% normal goat serum, 2% BSA in PBS,
followed by 8 min Avidin/Biotin block. The primary antibody
incubation (3 hr) was followed by 32 min incubation with
biotinylated anti-mouse IgG (ABC kit from Vector labs), 60 min
incubation with biotinylated anti-goat IgG (ABC kit from
Vector labs), or biotinylated anti-rabbit antibody at 1:200
dilution (Vectastain ABC kit). The secondary detection was
performed with Streptavidin-HRP D (Ventana Medical Sys-
tems), followed by incubation with Tyramide-Alexa Fluor 488
(Invitrogen) or Tyramide Alexa Fluor 568 (Invitrogen). Stained
slides were viewed with a Zeiss Axiovert 200 widefield
microscope and pictures were acquired using MetaMorph
software 7.1 (Molecular Devices).
Western blotting
For western blotting, gastric membrane fractions were
prepared as previously described [7]. Three stomachs from
12-month-old Kcne2
+/+ and Kcne2
2/2 mice were removed post-
mortem, cut open along the curvatura ventriculi major, cleared
of ingesta and immediately snap-frozen in liquid nitrogen.
Stomachs were then homogenized in a buffer containing
50 mM Tris-HCl, 150 mM NaCl, 100 ug/ml PMSF, 1 ug/ml
Nonidet P40, 0.5% SDS and 0.5% sodium orthovanadate, then
incubated on ice for 30 min and centrifuged at 120006g for
20 min at 4uC. Protein concentration of the supernatant was
measured according to the Bradford method. Total protein
(40 mg/lane) was loaded into a pre-cast tris-glycine 4–20% gel
(Jule Inc, Milford, CT) and separated by electrophoresis.
Proteins were then transferred onto a PVDF membrane (Bio-
Rad, Hercules, CA), and blocked with 5% milk, 0.05% Tween-
20 in PBS for 12 hours at 4uC on a rocker. Primary antibody
incubations (4 hr, RT in 1% milk, 0.05% Tween-20, PBS,
‘Buffer A’) were: 1:2000 anti-Cyclin-D1 (Abcam); 1:5000 anti-
GAPDH (Abcam). Membranes were washed 4 times, 20 min
each with antibody incubation buffer then incubated with the
appropriate secondary antibodies (BioRad) diluted 1:10000 in
Buffer A for 2 hr at RT then washed 462 0m i ne a c hw i t hB u f f e r
A and once for 5 min with PBS. Membranes were incubated for
1 min with the SuperSignal ECL reagent (Pierce)t h e ne x p o s e d
on BioMax Light Film (Kodak) and developed using an RP X-
OMAT Processor (Kodak).
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